Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H7O3.Na |
| Molecular Weight | 210.1612 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].OC1=CC2=C(C=CC=C2)C=C1C([O-])=O
InChI
InChIKey=ZCNGWQCRXUGQCW-UHFFFAOYSA-M
InChI=1S/C11H8O3.Na/c12-10-6-8-4-2-1-3-7(8)5-9(10)11(13)14;/h1-6,12H,(H,13,14);/q;+1/p-1
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C11H7O3 |
| Molecular Weight | 187.1715 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0034976 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26983645 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Inactive ingredient | ALCOPAR Approved UseHelminthiasis |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator​
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 7.0 |
inconclusive [IC50 39.9149 uM] | |||
Page: 5.0 |
no [IC50 30.6379 uM] | |||
Page: 113.0 |
no | |||
Page: 6.0 |
yes [IC50 35.3422 uM] | |||
Page: 7.0 |
yes [IC50 39.9149 uM] | |||
Page: 12.0 |
yes [IC50 56.3813 uM] |
Tox targets
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
Page: 113.0 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26983645
In a preclinical study, mice received hydroxynaphthoic acid sodium salt (150 mg/kg/day) twice a day for 2 weeks by gavage.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26983645
The stable HEK 293 cell line harboring a reporter gene expressed by human grp78 promoter was treated with PA media containing 300 uM of palmitate to induce ER stress and then serial dilutions of hydroxynaphthoic acid were applied (from 0.01 to 1 mM) for 22 h. The drug inhibited ER stress with IC50 value of 44.9 uM. It also reduced PA-induced p-JNK and p-IRS-1(S307) levels in dose-dependent manners in HepG2 cells when incubated for 2 h at concentrations 0.1, 0.3, 0.5 mM. At 0.3 mM hydroxynaphthoic acid restored insulin sensitivity suppressed by PA. When fully differentiated 3T3-L1 cells were co-incubated with or without thapsigargin (Tg) and hydroxynaphthoic acid (30, 100, 300 uM) for 18 h, the acid augmented GLUT4 translocation by sensitizing insulin and PPARgamma signaling and showed 100-fold activation at 300 uM. The drug (0.1 and 0.3 mM) protected INS-1 cells from cell death after the incubation with 300 uM PA in combination with 25 mM glucose for 18 h.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 19:33:54 GMT 2025
by
admin
on
Mon Mar 31 19:33:54 GMT 2025
|
| Record UNII |
XU99AT42HZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
23672297
Created by
admin on Mon Mar 31 19:33:54 GMT 2025 , Edited by admin on Mon Mar 31 19:33:54 GMT 2025
|
PRIMARY | |||
|
14206-62-3
Created by
admin on Mon Mar 31 19:33:54 GMT 2025 , Edited by admin on Mon Mar 31 19:33:54 GMT 2025
|
PRIMARY | |||
|
238-063-3
Created by
admin on Mon Mar 31 19:33:54 GMT 2025 , Edited by admin on Mon Mar 31 19:33:54 GMT 2025
|
PRIMARY | |||
|
XU99AT42HZ
Created by
admin on Mon Mar 31 19:33:54 GMT 2025 , Edited by admin on Mon Mar 31 19:33:54 GMT 2025
|
PRIMARY | |||
|
DTXSID0065729
Created by
admin on Mon Mar 31 19:33:54 GMT 2025 , Edited by admin on Mon Mar 31 19:33:54 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
|